世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037586

ファージ療法の世界市場(2024-2028)

TechNavio

Global Phage Therapy Market 2024-2028

発刊日 2024/02/02

言語英語

体裁PDF/156ページ

ライセンス/価格156ページ

0000037586

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ファージ療法市場は2023年から2028年に5,100万米ドル、予測期間中のCAGRは17.41%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、抗生物質に対するファージ療法の利点、動物の健康に対するファージ療法の用途の増加、ヒトの健康に対するファージ療法の用途の増加が牽引しています。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ 大腸菌
      ◇ 黄色ブドウ球菌
      ◇ サルモネラ
      ◇ その他
    ➣ 用途別
      ◇ 動物の健康
      ◇ 食品業界
      ◇ 水産養殖など
    ➣ 地域別
      ◇ ヨーロッパ
      ◇ 北アメリカ
      ◇ アジア
      ◇ 世界のその他の地域(ROW)

本調査では、今後数年間のファージ療法市場の成長を牽引する主要因の一つとして、ファージ療法への投資の増加を挙げています。また、ファージ療法の臨床試験の増加やベンダー間のパートナーシップの増加が、市場の大きな需要につながります。

ファージ療法市場に関するレポートは、次の分野をカバーしています。

  • ファージ療法市場の規模
  • ファージ療法市場の予測
  • ファージ療法市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Adaptive Phage Therapeutics
    ➣ APS Biocontrol Ltd.
    ➣ Armata Pharmaceuticals Inc.
    ➣ Astellas Pharma Inc.
    ➣ BiomX Inc.
    ➣ CJ CheilJedang Corp.
    ➣ Cytophage Technologies Inc.
    ➣ Eliava Biopreparation LLC
    ➣ Intralytix Inc.
    ➣ iNtRON Biotechnology Inc.
    ➣ JSC NPO Microgen
    ➣ Locus Biosciences Inc.
    ➣ Micreos, Micromir
    ➣ Nexabiome
    ➣ Proteon Pharmaceuticals S.A.
    ➣ Taconic Biosciences Inc.
    ➣ TechnoPhage
    ➣ ZeptoMetrix LLC
    ➣ Vitalis Wellness LLP

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global phage therapy market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global phage therapy market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Escherichia coli - Market size and forecast 2023-2028
Exhibit 34: Chart on Escherichia coli - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Escherichia coli - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Escherichia coli - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Escherichia coli - Year-over-year growth 2023-2028 (%)
6.4 Staphylococcus aureus - Market size and forecast 2023-2028
Exhibit 38: Chart on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
6.5 Salmonella - Market size and forecast 2023-2028
Exhibit 42: Chart on Salmonella - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Salmonella - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Salmonella - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Salmonella - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Exhibit 50: Market opportunity by Product ($ million)
Exhibit 51: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application
7.1 Market segments
Exhibit 52: Chart on Application - Market share 2023-2028 (%)
Exhibit 53: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 54: Chart on Comparison by Application
Exhibit 55: Data Table on Comparison by Application
7.3 Animal health - Market size and forecast 2023-2028
Exhibit 56: Chart on Animal health - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Animal health - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Animal health - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Animal health - Year-over-year growth 2023-2028 (%)
7.4 Food industry - Market size and forecast 2023-2028
Exhibit 60: Chart on Food industry - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Food industry - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Food industry - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Food industry - Year-over-year growth 2023-2028 (%)
7.5 Aquaculture and others - Market size and forecast 2023-2028
Exhibit 64: Chart on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Aquaculture and others - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Aquaculture and others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Application
Exhibit 68: Market opportunity by Application ($ million)
Exhibit 69: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Poland - Market size and forecast 2023-2028
Exhibit 99: Chart on Poland - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Poland - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Poland - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Poland - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Adaptive Phage Therapeutics
Exhibit 119: Adaptive Phage Therapeutics - Overview
Exhibit 120: Adaptive Phage Therapeutics - Product / Service
Exhibit 121: Adaptive Phage Therapeutics - Key offerings
12.4 APS Biocontrol Ltd.
Exhibit 122: APS Biocontrol Ltd. - Overview
Exhibit 123: APS Biocontrol Ltd. - Product / Service
Exhibit 124: APS Biocontrol Ltd. - Key offerings
12.5 Armata Pharmaceuticals Inc.
Exhibit 125: Armata Pharmaceuticals Inc. - Overview
Exhibit 126: Armata Pharmaceuticals Inc. - Product / Service
Exhibit 127: Armata Pharmaceuticals Inc. - Key offerings
12.6 CJ CheilJedang Corp.
Exhibit 128: CJ CheilJedang Corp. - Overview
Exhibit 129: CJ CheilJedang Corp. - Business segments
Exhibit 130: CJ CheilJedang Corp. - Key offerings
Exhibit 131: CJ CheilJedang Corp. - Segment focus
12.7 Cytophage Technologies Inc.
Exhibit 132: Cytophage Technologies Inc. - Overview
Exhibit 133: Cytophage Technologies Inc. - Product / Service
Exhibit 134: Cytophage Technologies Inc. - Key offerings
12.8 Intralytix Inc.
Exhibit 135: Intralytix Inc. - Overview
Exhibit 136: Intralytix Inc. - Product / Service
Exhibit 137: Intralytix Inc. - Key offerings
12.9 iNtRON Biotechnology Inc.
Exhibit 138: iNtRON Biotechnology Inc. - Overview
Exhibit 139: iNtRON Biotechnology Inc. - Product / Service
Exhibit 140: iNtRON Biotechnology Inc. - Key offerings
12.10 JSC NPO Microgen
Exhibit 141: JSC NPO Microgen - Overview
Exhibit 142: JSC NPO Microgen - Product / Service
Exhibit 143: JSC NPO Microgen - Key offerings
12.11 Locus Biosciences Inc.
Exhibit 144: Locus Biosciences Inc. - Overview
Exhibit 145: Locus Biosciences Inc. - Product / Service
Exhibit 146: Locus Biosciences Inc. - Key offerings
12.12 Micreos
Exhibit 147: Micreos - Overview
Exhibit 148: Micreos - Product / Service
Exhibit 149: Micreos - Key offerings
12.13 Micromir
Exhibit 150: Micromir - Overview
Exhibit 151: Micromir - Product / Service
Exhibit 152: Micromir - Key offerings
12.14 Nexabiome
Exhibit 153: Nexabiome - Overview
Exhibit 154: Nexabiome - Product / Service
Exhibit 155: Nexabiome - Key offerings
12.15 Proteon Pharmaceuticals S.A.
Exhibit 156: Proteon Pharmaceuticals S.A. - Overview
Exhibit 157: Proteon Pharmaceuticals S.A. - Product / Service
Exhibit 158: Proteon Pharmaceuticals S.A. - Key offerings
12.16 TechnoPhage
Exhibit 159: TechnoPhage - Overview
Exhibit 160: TechnoPhage - Product / Service
Exhibit 161: TechnoPhage - Key offerings
12.17 ZeptoMetrix LLC
Exhibit 162: ZeptoMetrix LLC - Overview
Exhibit 163: ZeptoMetrix LLC - Product / Service
Exhibit 164: ZeptoMetrix LLC - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations

この商品のレポートナンバー

0000037586

TOP